These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8993676)

  • 41. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The adenosine A2A receptor agonist CGS 21680 exhibits antipsychotic-like activity in Cebus apella monkeys.
    Andersen MB; Fuxe K; Werge T; Gerlach J
    Behav Pharmacol; 2002 Dec; 13(8):639-44. PubMed ID: 12478214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Behavioral effects of the aqueous extract of Guiera senegalensis in mice and rats.
    Amos S; Kolawole E; Akah P; Wambebe C; Gamaniel K
    Phytomedicine; 2001 Sep; 8(5):356-61. PubMed ID: 11695878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
    Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maternal exposure to diphenhydramine during the fetal period in rats: effects on physical and neurobehavioral development and on neurochemical parameters.
    Moraes AP; Schwarz A; Spinosa HS; Florio JC; Bernardi MM
    Neurotoxicol Teratol; 2004; 26(5):681-92. PubMed ID: 15315817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclodiene insecticides-induced changes in the central depressive effect of chlorpromazine in rats.
    Balasubramaniam E; Paul V; Kazi M
    Indian J Physiol Pharmacol; 1995 Jul; 39(3):231-6. PubMed ID: 8550115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A neuropsychopharmacological profile of "Cinkara", a polyherbal preparation.
    Sakina MR; Khan EA; Hamdard ME; Dandiya PC
    Indian J Physiol Pharmacol; 1989; 33(1):43-6. PubMed ID: 2737746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. behavior of rats and mice administered active metabolites of fluphenazine, 7-hydroxy-fluphenazine and fluphenazine-sulfoxide.
    Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):76-85. PubMed ID: 7194019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and CNS activity of new 1-alkyl-2-aryl-7-hydroxy-5(1H)oxo-imidazo[1,2-a]pyrymidines.
    Matosiuk D; Tkaczyński T; Stefańczyk J
    Acta Pol Pharm; 1996; 53(3):209-12. PubMed ID: 8960291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-linearity in combined effects of ELF magnetic field and amphetamine on motor activity in rats.
    Pesić V; Janać B; Jelenković A; Vorobyov V; Prolić Z
    Behav Brain Res; 2004 Apr; 150(1-2):223-7. PubMed ID: 15033296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of dexfenfluramine on dopamine dependent behaviours in rats.
    Thorat VM; Gaonkar RK; Bhosale KB; Balsara JJ
    Indian J Physiol Pharmacol; 2005 Jan; 49(1):39-48. PubMed ID: 15881857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative studies on the central effects of angiotensin II and of its fragments.
    Klusha V; Georgiev VP; Petkov VD; Markovska VL; Svirskis SV; Mutzenietze RK; Anuans ZE
    Acta Physiol Pharmacol Bulg; 1986; 12(2):7-13. PubMed ID: 3766165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
    Skuza G; Rogóz Z; Wieczorek A
    Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Some behavioural effects of carbamazepine - comparison with haloperidol.
    Nowakowska E; Kus K; Czubak A; Glowacka D; Matschay A
    J Physiol Pharmacol; 2007 Jun; 58(2):253-64. PubMed ID: 17622695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavioral effects of phenoxybenzamine administered intraventricularly in rats.
    Zebrowska-Lupina I
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):223-31. PubMed ID: 945052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.